Citadel Advisors - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 41 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2022$134,000
-89.7%
59,380
-51.8%
0.00%
Q3 2021$1,297,000
-53.2%
123,258
-56.5%
0.00%
-100.0%
Q2 2021$2,769,000
-72.5%
283,667
-59.0%
0.00%
-50.0%
Q1 2021$10,063,000692,5370.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Duquesne Family Office 100,000$231,0000.01%
FNY Investment Advisers, LLC 3,500$8,0000.01%
LEO BROKERAGE, LLC 14,845$34,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 37,900$88,0000.00%
UBS Group AG 13,618$31,0000.00%
RHUMBLINE ADVISERS 16,169$37,0000.00%
Ellevest, Inc. 19$00.00%
TWO SIGMA INVESTMENTS, LP 62,184$144,0000.00%
FMR LLC 179$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 10,375$24,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders